Johnson & Johnson offered a $6.5 billion settlement deal to plaintiffs in a talcum powder lawsuit over alleged ovarian cancer, with 54,000 people suing. The deal needs 75% approval from claimants within 3 months to proceed.
Key Points
Johnson & Johnson offering $6.5 billion settlement to 54,000 plaintiffs over talcum powder lawsuit.
Deal requires 75% approval from claimants within 3 months to proceed.
Most lawsuits are related to ovarian cancer caused by talc contaminated with asbestos.
Pros
Offering substantial compensation to plaintiffs affected by alleged ovarian cancer.
Potential closure for thousands of claimants after years of legal battles.
Cons
No admission of fault from Johnson & Johnson.
Uncertainty around the amount each plaintiff will receive.